Roles for Growth Factors in Cancer Progression
The major signaling pathways stimulated by receptor tyrosine kinases (RTKs) and TGF-β receptors are shown schematically. Note that TGF-β can stimulate both the canonical pathway, and non-canonical pathways (not shown), including some components which are listed here under RTK. Activation of the phospholipid PI3K pathway may be achieved by binding of the regulatory p85 subunit to an activated RTK or through the activation of the small GTP-binding protein RAS. On activation, PI3K induces formation of phosphatidylinositol(3,4,5)-phosphate (PIP3), which serves as a docking site for proteins containing phospholipid-binding domains (e.g., PH domains), including protein kinase B and AKT. Recruitment of AKT to the membrane enables its phosphorylation on two stimulatory residues; one of these phosphorylation events (threonine-308) is mediated by PDK, whereas the other (serine-473) is mediated by mTorC2. PTEN and INPP4B are phophatases that abolish AKT activation and act as tumor suppressors. AKT has a large number of substrates that regulate mainly survival and metabolism. One example is the proapoptotic protein BAD, which is inhibited following phosphorylation by AKT. BAD induces permeabilization of the mitochondrial membrane to enable release of cytochrome C. The latter is involved in the generation of a protein complex known as the apoptosome, which cleaves pro-caspases to generate the active form of caspase-9. The ERK pathway is a multiple layer kinase cascade, in which the most distal MAPK elements are activated on tyrosine/threonine phosphorylation. In the ERK1/2 kinase pathway, binding of a ligand to an RTK enables auto-phosphorylation and recruitment of adaptors like GRB2 and SHC. The adaptors mediate recruitment of a GTP/GDP exchange protein, SOS, which loads GTP onto RAS. Active, GTP-loaded RAS molecules stimulate RAF kinases, which instigate the cascade leading to MEK (MAPK kinase) and then to ERK activation. Active ERK molecules translocate to the nucleus to stimulate multiple transcription programs essential for cell cycle progression and cell migration. The phopholipase Cγ-protein kinase C (PKC) pathway is instigated on recruitment of PLCγ to ligand-bound receptors. The activated enzyme hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) to form two second messengers, diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3). Binding of IP3 to receptors on the membrane of the endoplasmic reticulum leads to Ca2+ release. Free cytosolic calcium ions, together with DAG, activate members of the protein kinase C (PKC) family, resulting in the phosphorylation of various effector proteins. In addition, cytosolic Ca2+ activates the calcium/calmodulin-dependent protein kinases and phosphatases. The SMAD signaling pathway is the canonical signaling pathway of TGF-β family members. TGF-β dimers bind to a type II receptor, which recruits and phosphorylates a type I receptor. The type I receptor then recruits and phosphorylates a receptor-regulated SMAD (R-SMAD). R-SMAD then binds to the common SMAD (SMAD4) to form a heterodimeric complex. This complex then translocates into the nucleus, where it acts as a transcription factor.
Publication
Roles for Growth Factors in Cancer Progression. () Esther Witsch, et al. Physiology (Bethesda). ;25(2):85-101. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TGF-BR | TGFBR | famplex_relations | TGFBR1 | 7046 |
| Homo sapiens | Primates | TGF-BR | TGFBR | famplex_relations | TGFBR2 | 7048 |
| Homo sapiens | Primates | TGF-BR | TGFBR | famplex_relations | TGFBR3 | 7049 |
| Homo sapiens | Primates | PLCY | PLCG | famplex_relations | PLCG1 | 5335 |
| Homo sapiens | Primates | PLCY | PLCG | famplex_relations | PLCG2 | 5336 |
| Homo sapiens | Primates | GR82/sos | SOS | ncbigene_synonym | XYLT2 | 64132 |
| Homo sapiens | Primates | GR82/sos | SOS | famplex_relations | SOS1 | 6654 |
| Homo sapiens | Primates | GR82/sos | SOS | famplex_relations | SOS2 | 6655 |
| Homo sapiens | Primates | SMAD2 | SMAD2 | ncbigene_symbol | SMAD2 | 4087 |
| Homo sapiens | Primates | SMAD2/3 | SMAD3 | ncbigene_symbol | SMAD3 | 4088 |
| Homo sapiens | Primates | PKC | PKC | ncbigene_synonym | PRRT2 | 112476 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCA | 5578 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCB | 5579 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCD | 5580 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCE | 5581 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCG | 5582 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCH | 5583 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCI | 5584 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCQ | 5588 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKCZ | 5590 |
| Homo sapiens | Primates | PKC | PKC | famplex_relations | PRKD3 | 23683 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | RAF | RAF | ncbigene_synonym | ZHX2 | 22882 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | ARAF | 369 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | BRAF | 673 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | RAF1 | 5894 |
| Homo sapiens | Primates | SMAD6/7 | SMAD7 | ncbigene_symbol | SMAD7 | 4092 |
| Homo sapiens | Primates | SMAD6/7 | SMAD6 | ncbigene_symbol | SMAD6 | 4091 |
| Homo sapiens | Primates | SMAD4 | SMAD4 | ncbigene_symbol | SMAD4 | 4089 |
| Homo sapiens | Primates | MEK1 | MEK1 | ncbigene_synonym | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK1/2 | MEK2 | ncbigene_synonym | MAP2K2 | 5605 |
| Homo sapiens | Primates | TorC2 | TORC2 | ncbigene_synonym | CRTC2 | 200186 |
| Homo sapiens | Primates | ERK1 | ERK1 | ncbigene_synonym | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK1/2 | ERK2 | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | BAD | BAD | ncbigene_symbol | BAD | 572 |
| Homo sapiens | Primates | ERF) | ERF | ncbigene_symbol | ERF | 2077 |
| Homo sapiens | Primates | ERF) | ERF | ncbigene_synonym | ETF1 | 2107 |
| Homo sapiens | Primates | Myc, | MYC | ncbigene_symbol | MYC | 4609 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP1 | 834 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP2 | 835 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP4 | 837 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP5 | 838 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP6 | 839 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP8 | 841 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP9 | 842 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP10 | 843 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP12 | 100506742 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP14 | 23581 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP3 | 836 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP7 | 840 |
| Homo sapiens | Primates | FOS | FOS | ncbigene_symbol | FOS | 2353 |
| Homo sapiens | Primates | FOS | FOS | famplex_relations | FOSB | 2354 |
| Homo sapiens | Primates | FOS | FOS | famplex_relations | FOSL1 | 8061 |
| Homo sapiens | Primates | FOS | FOS | famplex_relations | FOSL2 | 2355 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA | |||
| Cardiomyopathy | NA | |||
| Lung cancer | NA | |||
| Noonan syndrome | NA |